Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -2.91%59 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates TSE:6029 with a GF Score™ of 59/100 and a GF Value™ of 円140.45 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Artra Group ranks worse than 60.36% on this metric.
The historical rank and industry rank for Artra Group's Days Payable or its related term are showing as below:
TSE:6029'
s Days Payable Range Over the Past 10 Years
Min: 10.88 Med: 41.03 Max: 51.84
Current: 45.37
During the past 13 years, Artra Group's highest Days Payable was 51.84. The lowest was 10.88. And the median was 41.03.
TSE:6029's Days Payable is ranked worse than 60.36% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.32
vs TSE:6029: 45.37
Artra Group's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
stayed the same
Artra Group Days Payable Related Terms
Artra Group Days Payable Historical Data
* Premium members only.
The historical data trend for Artra Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Artra Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Artra Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Artra Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Artra Group and its competitors. Over the past decade, Artra Group's Days Payable has ranged from 10.88 to 51.84. According to the industry distribution chart, Artra Group ranks #367 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 60.4%.
Is Artra Group's Days Payable too high?
Artra Group's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 10.88 to a high of 51.84. Based on the distribution chart, Artra Group ranks #367 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Artra Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #367 out of 608 companies for Days Payable. This places Artra Group in the lower half of its industry. The industry median Days Payable is 57.32. Historically, Artra Group's own Days Payable has ranged from 10.88 to 51.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.32, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.45, compared to a current price of 円200.00 — trading 42.4% above its estimated fair value. The current Days Payable is 0.00. Artra Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円200.00 is trading 42.4% above its estimated GF Value™ of 円140.45.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Days Payable: 0.00
GF Value™: 円140.45 vs. price of 円200.00 (42.4% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
59GF Score
Get the complete analysis for TSE:6029
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
